back to Australia directory
australia clinical guidance

Polycystic ovary syndrome (PCOS)

A detailed Australian summary of polycystic ovary syndrome (pcos), with source-attributed priorities, a practical workflow, safety escalation and state or territory implementation boundaries.

JurisdictionAustralia
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceHealthcare professionals practising in Australia
This is an iatroX educational summary of named Australia sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Apply current TGA product information, PBS restrictions, state or territory law, local referral criteria, formulary and antimicrobial policy. A national recommendation does not create uniform service access.

Scope

Diagnose using the 2023 evidence-based criteria after excluding thyroid, prolactin, non-classic adrenal and other causes; adolescent criteria are stricter. Assess menstrual pattern, hyperandrogenism, fertility goals, weight stigma, sleep, blood pressure, glucose, lipids, depression and eating disorder risk. This summary is limited to the population, decisions and escalation boundaries stated in the named source.
sources for this section:2023 PCOS guideline

The Bottom Line

  • Diagnose using the 2023 evidence-based criteria after excluding thyroid, prolactin, non-classic adrenal and other causes; adolescent criteria are stricter.
  • Assess menstrual pattern, hyperandrogenism, fertility goals, weight stigma, sleep, blood pressure, glucose, lipids, depression and eating disorder risk.
  • An oral glucose tolerance test is the most accurate glycaemic assessment in higher-risk PCOS settings under the guideline.
  • Provide individualized lifestyle support focused on health and function, and protect the endometrium when prolonged amenorrhoea is present.
sources for this section:2023 PCOS guideline

Practical clinical workflow

1

Topic-specific assessment action

Diagnose using the 2023 evidence-based criteria after excluding thyroid, prolactin, non-classic adrenal and other causes; adolescent criteria are stricter.
2

Topic-specific diagnostic action

Provide individualized lifestyle support focused on health and function, and protect the endometrium when prolonged amenorrhoea is present.
3

Topic-specific management action

Choose combined hormonal therapy, metformin, anti-androgen or fertility treatment according to the dominant goal and contraindications.
4

Topic-specific follow-through

Anti-androgen treatment requires effective contraception because fetal androgen effects are possible and benefit takes months.
sources for this section:2023 PCOS guideline

Safety boundaries and escalation

  • Rapid virilisation, very high androgen, pelvic mass symptoms, severe bleeding or acute pregnancy-related pain requires urgent alternative-diagnosis assessment.
  • Obstructive sleep apnoea symptoms merit assessment independent of body size because prevalence is increased in PCOS.
sources for this section:2023 PCOS guideline

Implementation

The named source is national or binational guidance used in Australia, but referral access, public-health directions, formularies and funded services can still differ by state, territory and health service. Check current TGA product information for medicines. Offer culturally safe care and use the NACCHO鈥揜ACGP National Guide where Aboriginal and Torres Strait Islander preventive or chronic-care recommendations differ.
sources for this section:2023 PCOS guideline

Clinical use boundary

This independently written summary is not an official guideline. Check the linked source version, current TGA-approved product information where medicines are involved, and the applicable state, territory and local pathway at the point of care.

sources for this section:2023 PCOS guideline

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. Monash UniversityInternational Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome2023 guideline 路 accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the Australia question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.